CDC Morbidity & Mortality Weekly Report: Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants -- 24 States, December 2024-April 2025
November 28, 2025
November 28, 2025
ATLANTA, Georgia, Nov. 28 (TNSLrpt) -- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention issued the following document as part of its Morbidity and Mortality Weekly Report (No. 37) on November 20, 2025, entitled "Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants -- 24 States, December 2024-April 2025.":
Here are excerpts:
* * *
Summary
Wh . . .
Here are excerpts:
* * *
Summary
Wh . . .